Journal of Clinical Pharmacy & Therapeutics

Drug–drug interactions and adverse drug reactions: the bollards and flashing lights syndrome
pp. 97-99(3)
Author: Li Wan Po, A.

Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?
pp. 101-104(4)
Authors: Leone, H.; Polsonetti, B. W.

Comparison of Prilosec OTC^TM (omeprazole magnesium 20·6 mg) to placebo for 14 days in the treatment of frequent heartburn
pp. 105-112(8)
Authors: Allgood, L. D.; Grender, J. M.; Shaw, M. J.; Peura, D. A.

Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain
pp. 113-120(8)
Authors: Malonne, H.; Coffiner, M.; Fontaine, D.; Sonet, B.; Sereno, A.; Peretz, A.; Vanderbist, F.

Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method
pp. 121-132(12)
Authors: Desfrere, L.; Zohar, S.; Morville, P.; Brunhes, A.; Chevret, S.; Pons, G.; Moriette, G.; Rey, E.; Treluyer, J. M.

Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial
pp. 133-138(6)
Authors: Amini, H.; Aghayan, S.; Jalili, S. A.; Akhondzadeh, S.; Yahyazadeh, O.; Pakravan-Nejad, M.

Comparison of the effect of aminophylline and low PEEP vs. high PEEP on EGF concentration in critically ill patients with ALI/ARDS
pp. 139-144(6)
Authors: Salari, P.; Mojtahedzadeh, M.; Najafi, A.; Sadraie, S.; Bahaadini, K.; Moharreri, M.; Hadavand, N.; Abdollahi, M.

Adoption of celecoxib and rofecoxib: a nationwide database study
pp. 145-152(8)
Authors: Helin-Salmivaara, A.; Huupponen, R.; Virtanen, A.; Klaukka, T.

Grapefruit juice–nifedipine interaction: possible involvement of several mechanisms
pp. 153-158(6)
Authors: Odou, P.; Ferrari, N.; Barthélémy, C.; Brique, S.; Lhermitte, M.; Vincent, A.; Libersa, C.; Robert, H.

Population pharmacokinetic investigation of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants
pp. 159-163(5)
Authors: Yukawa, E.; Suematsu, F.; Yukawa, M.; Minemoto, M.

The impact of socioeconomic and demographic factors on the utilization of smoking cessation medications in patients hospitalized with cardiovascular disease in Nova Scotia, Canada
pp. 165-171(7)
Authors: Whelan, A. M.; Cooke, C. A.; Sketris, I. S.

High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans
pp. 173-178(6)
Authors: Poon, I. O.; Braun, U.

Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects
pp. 179-184(6)
Authors: Critchley, J. A. J. H.; Critchley, L. A. H.; Anderson, P. J.; Tomlinson, B.

A study of the in vitro interaction between lidocaine and premedications using human liver microsomes
pp. 185-188(4)
Authors: Nagashima, A.; Tanaka, E.; Inomata, S.; Honda, K.; Misawa, S.

Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysis
pp. 189-192(4)
Authors: Ozaki, H.; Ishikawa, C. T.; Ishii, T.; Toyoda, A.; Murano, T.; Miyashita, Y.; Shirai, K.

Erratum
pp. 192-192(1)